Targeting the overproduction of peroxynitrite for the prevention and reversal of paclitaxel-induced neuropathic pain

Journal of Neuroscience

Volumn 32, Issue 18, 2012, Pages 6149-6160

  Salvemini, Daniela ^a   Doyle, Timothy ^a   Chen, Zhoumou ^a   Muscoli, Carolina ^a,b,c   Bryant, Leesa ^a   Esposito, Emanuela ^d   Cuzzocrea, Salvatore ^d   Dagostino, Concetta ^c   Ryerse, Jan ^a   Rausaria, Smita ^e   Kamadulski, Andrew ^e   Neumann, William L ^e  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c Headache and Pain Unit   (Italy)

^d IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^e SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; COPPER ZINC SUPEROXIDE DISMUTASE; FETMPYP5; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE AMMONIA LIGASE; GLUTAMATE TRANSPORTER; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; MANGANESE SUPEROXIDE DISMUTASE; MNTE-2-PYP5; N (G) NITROARGININE METHYL ESTER; N6 (1 IMINOETHYL) LYSINE; NITRIC OXIDE SYNTHASE; PACLITAXEL; PEROXYNITRITE; PORPHYRIN DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SRI110; SRI6; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BEHAVIOR; CATALYST; CONTROLLED STUDY; DECOMPOSITION; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYPERALGESIA; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD;

ANIMALS; ANTINEOPLASTIC AGENTS; CYTOKINES; DRUG DELIVERY SYSTEMS; MALE; NEURALGIA; PACLITAXEL; PEROXYNITROUS ACID; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84860333152     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.6343-11.2012     Document Type: Article

References (81)

1. Aldskogius H, Liu L, Svensson M (1999) Glial responses to synaptic damage and plasticity. J Neurosci Res 58:33-41.
2. Batinic-Haberle I, Reboucas JS, Spasojevich I (2010) Superoxide dismutase mimics: chemistry, pharmacology and therapeutic potential. Antioxid Redox Signal 13:877-918.
3. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxynitrite: implications for en-dothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 87:1620-1624.
4. Bennett GJ (2010) Pathophysiology and animal models of cancer-related painful peripheral neuropathy. Oncologist 15 [Suppl 2]:9-12.
5. Bennett GJ, Liu GK, Xiao WH, Jin HW, Siau C (2011) Terminal arbor de-generation-a novel lesion produced by the antineoplastic agent paclitaxel. Eur J Neurosci 33:1667-1676.
6. Bensinger RE, Johnson CM (1981) Luminol assay for superoxide dismutase. Anal Biochem 116:142-145.
7. Cata JP, Weng HR, Chen JH, Dougherty PM (2006a) Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia. Neu-roscience 138:329-338.
8. Cata JP, Weng HR, Lee BN, Reuben JM, Dougherty PM (2006b) Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy. Minerva Anestesiol 72:151-169.
9. Cata JP, Weng HR, Dougherty PM (2008) The effects of thalidomide and minocycline on taxol-induced hyperalgesia in rats. Brain Res 1229: 100-110.
10. Chang RH, Feng MH, Liu WH, Lai MZ (1997) Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology 90:364-369.
11. Chen Y, Boettger MK, Reif A, Schmitt A, Uçeyler N, Sommer C (2010) Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice. Mol Pain 6:13.
12. Dahan L, Sadok A, Formento JL, Seitz JF, Kovacic H (2009) Modulation of cellular redox state underlies antagonism between oxaliplatin and cetuximab in human colorectal cancer cell lines. Br J Pharmacol 158:610-620.
13. Decraene D, Smaers K, Gan D, Mammone T, Matsui M, Maes D, Declercq L, Garmyn M (2004) A synthetic superoxide dismutase/catalase mimetic (EUK-134) inhibits membrane-damage-induced activation of mitogen-activated protein kinase pathways and reduces p53 accumulation in ultraviolet B-exposed primary human keratinocytes. J Invest Dermatol 122:484-491.
14. DeLeo JA, Yezierski RP (2001) The role of neuroinflammation and neuro-immune activation in persistent pain. Pain 90:1-6.
15. Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441-462.
16. Doyle T, Bryant L, Muscoli C, Cuzzocrea S, Esposito E, Chen Z, Salvemini D (2010) Spinal NADPH oxidase is a source of superoxide in the development of morphine-induced hyperalgesia and antinociceptive tolerance. Neurosci Lett 483:85-89.
17. Farquhar-Smith P (2011) Chemotherapy-induced neuropathic pain. Curr Opin Support Palliat Care 5:1-7.
18. Ferrer-Sueta G, Radi R (2009) Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem Biol 4:161-177.
19. Flatters SJ, Bennett GJ (2006) Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mito-chondrial dysfunction. Pain 122:245-257.
20. Fries DM, Paxinou E, Themistocleous M, Swanberg E, Griendling KK, Salvemini D, Slot JW, Heijnen HF, Hazen SL, Ischiropoulos H (2003) Expression of inducible nitric-oxide synthase and intracellular protein tyrosine nitration in vascular smooth muscle cells: role of reactive oxygen species. J Biol Chem 278:22901-22907.
21. Glantz MJ, Choy H, Kearns CM, Mills PC, Wahlberg LU, Zuhowski EG, Calabresi P, Egorin MJ (1995) Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors. J Natl Cancer Inst 87:1077-1081.
22. Görg B, Wettstein M, Metzger S, Schliess F, Häussinger D (2005) Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology 41:1065-1073.
23. Hunt JA, Lee J, Groves JT (1997) Amphiphilic peroxynitrite decomposition catalysts in liposomal assemblies. Chem Biol 4:845-858.
24. Itamochi H, Oishi T, Shimada M, Sato S, Uegaki K, Naniwa J, Nonaka M, Terakawa N, Kigawa J, Harada T (2011) Inhibiting the mTOR pathway synergistically enhances cytotoxicity in ovarian cancer cells induced by etoposide through upregulation of c-Jun. Clin Cancer Res 17:4742-4750.
25. Joshi G, Aluise CD, Cole MP, Sultana R, Pierce WM, Vore M, St Clair DK, Butterfield DA (2010) Alterations in brain antioxidant enzymes and re-dox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain. Neuroscience 166:796-807.
26. Kapadia SE, LaMotte CC (1987) Deafferentation-induced alterations in the rat dorsal horn: I. Comparison of peripheral nerve injury vs. rhizotomy effects on presynaptic, postsynaptic, and glial processes. J Comp Neurol 266:183-197.
27. Kimura H, Nakano M (1988) Highly sensitive and reliable chemilumines-cence method for the assay of superoxide dismutase in human erythro-cytes. FEBS Lett 239:347-350.
28. Koppenol WH, Moreno JJ, Pryor WA, Ischiropoulos H, Beckman JS (1992) Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem Res Toxicol 5:834-842.
29. Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neuro-chem 94:819-827.
30. Kriedt CL, Baldassare J, Shah M, Klein C (2010) Zinc functions as a cyto-toxic agent for prostate cancer cells independent of culture and growth conditions. J Exp Ther Oncol 8:287-295.
31. Kugler P (1993) Enzymes involved in glutamatergic and GABAergic neu-rotransmission. Int Rev Cytol 147:285-336.
32. Lacroix M, Leclercq G (2004) Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83:249-289.
33. Ledeboer A, Liu T, Shumilla JA, Mahoney JH, Vijay S, Gross MI, Vargas JA, Sultzbaugh L, Claypool MD, Sanftner LM, Watkins LR, Johnson KW (2006) The glial modulatory drug AV411 attenuates mechanical allo- dynia in rat models of neuropathic pain. Neuron Glia Biol 2:279-291.
34. Ledeboer A, Jekich BM, Sloane EM, Mahoney JH, Langer SJ, Milligan ED, Martin D, Maier SF, Johnson KW, Leinwand LA, Chavez RA, Watkins LR (2007) Intrathecal interleukin-10 gene therapy attenuates paclitaxel- induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun 21:686-698.
35. Macmillan-Crow LA, Cruthirds DL (2001) Invited review: manganese su-peroxide dismutase in disease. Free Radic Res 34:325-336.
36. Massaad CA, Klann E (2010) Reactive Oxygen Species in the Regulation of Synaptic Plasticity and Memory. Antioxid Redox Signal 14:2013-2054.
37. McCord JM, Fridovich I (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049-6055.
38. Milligan ED, Watkins LR (2009) Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10:23-36.
39. Miñana MD, Kosenko E, Marcaida G, Hermenegildo C, Montoliu C, Grisolía S, Felipo V (1997) Modulation of glutamine synthesis in cultured astro-cytes by nitric oxide. Cell Mol Neurobiol 17:433-445.
40. Moncada S, Palmer RM, Higgs EA (1991) Nitric oxide: physiology, patho-physiology, and pharmacology. Pharmacol Rev 43:109-142.
41. Muscoli C, Cuzzocrea S, Ndengele MM, Mollace V, Porreca F, Fabrizi F, Esposito E, Masini E, Matuschak GM, Salvemini D (2007) Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice. J Clin Invest 117:3530-3539.
42. Muscoli C, Doyle T, Dagostino C, Bryant L, Chen Z, Watkins LR, Ryerse J, Bieberich E, Neumman W, Salvemini D (2010) Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. J Neurosci 30:15400-15408.
43. Peters CM, Jimenez-Andrade JM, Jonas BM, Sevcik MA, Koewler NJ, Ghilardi JR, Wong GY, Mantyh PW (2007) Intravenous paclitaxel administration in the rat induces a peripheral sensory neuropathy characterized by macrophage infiltration and injury to sensory neurons and their supporting cells. Exp Neurol 203:42-54.
44. Polomano RC, Mannes AJ, Clark US, Bennett GJ (2001) A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel. Pain 94:293-304.
45. Radi R, Cassina A, Hodara R, Quijano C, Castro L (2002) Peroxynitrite reactions and formation in mitochondria. Free Radic Biol Med 33:1451-1464.
46. Raghavendra V, Tanga F, DeLeo JA (2003) Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Ther 306:624-630.
47. Ramos KM, Lewis MT, Morgan KN, Crysdale NY, Kroll JL, Taylor FR, Harrison JA, Sloane EM, Maier SF, Watkins LR (2010) Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 169:1888-1900.
48. Randall LO, Selitto JJ (1957) A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111:409-419.
49. Rausaria S, Kamadulski A, Rath NP, Bryant L, Chen Z, Salvemini D, Neumann WL (2011a) Manganese(III) complexes of bis(hydroxyphenyl-)dipyrromethenes are potent orally active peroxynitrite scavengers. J Am Chem Soc 133:4200-4203.
50. Rausaria S, Ghaffari MM, Kamadulski A, Rodgers K, Bryant L, Chen Z, Doyle T, Shaw MJ, Salvemini D, Neumann WL (2011b) Retooling mangane-se(III) porphyrin-based peroxynitrite decomposition catalysts for selectivity and oral activity: a potential new strategy for treating chronic pain. J Med Chem 54:8658-8669.
51. Salter M, Knowles RG, Moncada S (1991) Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2 +)-independent nitric oxide synthases. FEBS Lett 291:145-149.
52. Salvemini D, Jensen MP, Riley DP, Misko TP (1998) Therapeutic manipulations of peroxynitrite. Drug News Perspect 11:204-214.
53. Salvemini D, Little JW, Doyle T, Neumann WL (2011) Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med 51:951-966.
54. Schildknecht S, Pape R, Müller N, Robotta M, Marquardt A, Bürkle A, Dre-scher M, Leist M (2011) Neuroprotection by minocycline due to direct and specific scavenging of peroxynitrite. J Biol Chem 286:4991-5002.
55. Schoeniger-Skinner DK, Ledeboer A, Frank MG, Milligan ED, Poole S, Martin D, Maier SF, Watkins LR (2007) Interleukin-6 mediates low-threshold mechanical allodynia induced by intrathecal HIV-1 envelope glycoprotein gp120. Brain BehavImmun 21:660-667.
56. Shah MR, Kriedt CL, Lents NH, Hoyer MK, Jamaluddin N, Klein C, Baldas-sare J (2009) Direct intra-tumoral injection of zinc-acetate halts tumor growth in a xenograft model of prostate cancer. J Exp Clin Cancer Res 28:84.
57. Siau C, Xiao W, Bennett GJ (2006) Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells. Exp Neurol 201:507-514.
58. Sies H, Masumoto H (1997) Ebselen as a glutathione peroxidase mimic and as a scavenger of peroxynitrite. Adv Pharmacol 38:229-246.
59. Sikora A, Zielonka J, Lopez M, Joseph J, Kalyanaraman B (2009) Direct oxidation of boronates by peroxynitrite: mechanism and implications in fluorescence imaging of peroxynitrite. Free Radic Biol Med 47:1401-1407.
60. Simons JM, Hart BA, Ip Vai Ching TR, Van Dijk H, Labadie RP (1990) Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med 8:251-258.
61. Smith CD, Carson M, van der Woerd M, Chen J, Ischiropoulos H, Beckman JS (1992) Crystal structure of peroxynitrite-modified bovine Cu,Zn superoxide dismutase. Arch Biochem Biophys 299:350-355.
62. Spasojevic I, Chen Y, Noel TJ, Fan P, Zhang L, Rebouças JS, St Clair DK, Batinic-Haberle I (2008) Pharmacokinetics of the potent redox-modulating manganese porphyrin, MnTE-2-PyP(5 +), in plasma and major organs of B6C3F1 mice. Free Radic Biol Med 45:943-949.
63. Størkson RV, Kjørsvik A, Tjølsen A, Hole K (1996) Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 65:167-172.
64. Swift S, Ellison AR, Kassner P, McCaffery I, Rossi J, Sinclair AM, Begley CG, Elliott S (2010) Absence of functional EpoR expression in human tumor cell lines. Blood 115:4254-4263.
65. Szabo C, Ischiropoulos H, Radi R (2007) Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:662-680.
66. Takagi N, Logan R, Teves L, Wallace MC, Gurd JW (2000) Altered interaction between PSD-95 and the NMDA receptor following transient global ischemia. J Neurochem 74:169-178.
67. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21:2580-2588.
68. Trotti D, Rossi D, Gjesdal O, Levy LM, Racagni G, Danbolt NC, Volterra A (1996) Peroxynitrite inhibits glutamate transporter subtypes. J Biol Chem 271:5976-5979.
69. Trotti D, Rolfs A, Danbolt NC, Brown RH Jr, Hediger MA (1999) SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter. Nat Neurosci 2:848.
70. Tsavaris N, Kosmas C, Vadiaka M, Kanelopoulos P, Boulamatsis D (2002) Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes. Br J Cancer 87:21-27.
71. Tsuda M, Inoue K, Salter MW (2005) Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 28:101-107.
72. Uppu RM, Squadrito GL, Pryor WA (1996) Acceleration of peroxynitrite oxidations by carbon dioxide. Arch Biochem Biophys 327:335-343.
73. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E, Muscoli C, Mollace V, Ndengele M, Ischiropoulos H, Salvemini D (2004) A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 309:869-878.
74. Watkins LR, Milligan ED, Maier SF (2001) Glial activation: a driving force for pathological pain. Trends Neurosci 24:450-455.
75. Weng HR, Aravindan N, Cata JP, Chen JH, Shaw AD, Dougherty PM (2005) Spinal glial glutamate transporters downregulate in rats with taxol-induced hyperalgesia. Neurosci Lett 386:18-22.
76. Wu ZZ, Lu HP, Chao CC (2010) Identification and functional analysis of genes which confer resistance to cisplatin in tumor cells. Biochem Pharmacol 80:262-276.
77. Xiao WH, Bennett GJ (2012) Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin. Pain 153:704-709.
78. Zhang H, Yoon SY, Dougherty PM (2012) Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of paclitaxel-induced painful neuropathy. J Pain 13:293-303.
79. Zheng FY, Xiao WH, Bennett GJ (2011) The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries. Neuroscience 176:447-454.
80. Zheng H, Xiao, WH, Bennett, GJ (2010) Mitotoxicity as the cause of the oainful peripheral neuropathies evoked by the chemotherapeutics, paclitaxel and oxaliplatin. IASP 13th World Congress on Pain, Montreal, Quebec, Abstract PW097.
81. Zheng H, Xiao WH, Bennett GJ (2011) Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy. Exp Neurol 232:145-161.